568 related articles for article (PubMed ID: 20806131)
1. [The optimult study concept - selective neoadjuvant chemoradiation therapy based on preoperative MRI].
Kreis ME; Junginger T; Rödel C; Heinemann V; Nikolaou K; Mansmann U; Jauch KW
Zentralbl Chir; 2010 Aug; 135(4):302-6. PubMed ID: 20806131
[TBL] [Abstract][Full Text] [Related]
2. Is final TNM staging a predictor for survival in locally advanced rectal cancer after preoperative chemoradiation therapy?
Kuo LJ; Liu MC; Jian JJ; Horng CF; Cheng TI; Chen CM; Fang WT; Chung YL
Ann Surg Oncol; 2007 Oct; 14(10):2766-72. PubMed ID: 17551794
[TBL] [Abstract][Full Text] [Related]
3. Long-term results using local excision after preoperative chemoradiation among selected T3 rectal cancer patients.
Bonnen M; Crane C; Vauthey JN; Skibber J; Delclos ME; Rodriguez-Bigas M; Hoff PM; Lin E; Eng C; Wong A; Janjan NA; Feig BW
Int J Radiat Oncol Biol Phys; 2004 Nov; 60(4):1098-105. PubMed ID: 15519780
[TBL] [Abstract][Full Text] [Related]
4. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
[TBL] [Abstract][Full Text] [Related]
5. Preoperative chemoradiation may not always be needed for patients with T3 and T2N+ rectal cancer.
Frasson M; Garcia-Granero E; Roda D; Flor-Lorente B; Roselló S; Esclapez P; Faus C; Navarro S; Campos S; Cervantes A
Cancer; 2011 Jul; 117(14):3118-25. PubMed ID: 21264832
[TBL] [Abstract][Full Text] [Related]
6. An interval >7 weeks between neoadjuvant therapy and surgery improves pathologic complete response and disease-free survival in patients with locally advanced rectal cancer.
Tulchinsky H; Shmueli E; Figer A; Klausner JM; Rabau M
Ann Surg Oncol; 2008 Oct; 15(10):2661-7. PubMed ID: 18389322
[TBL] [Abstract][Full Text] [Related]
7. The effect of circumferential tumor location in clinical outcomes of rectal cancer patients treated with total mesorectal excision.
Lee SH; Hernandez de Anda E; Finne CO; Madoff RD; Garcia-Aguilar J
Dis Colon Rectum; 2005 Dec; 48(12):2249-57. PubMed ID: 16400512
[TBL] [Abstract][Full Text] [Related]
8. [Local recurrence and survival rate after rectal cancer operations and multimodal therapy].
Thomschke D; Kyau-Ummen B; Halbfass HJ
Chirurg; 2002 Mar; 73(3):245-54. PubMed ID: 11963499
[TBL] [Abstract][Full Text] [Related]
9. Laparoscopic pelvic autonomic nerve-preserving surgery for patients with lower rectal cancer after chemoradiation therapy.
Liang JT; Lai HS; Lee PH
Ann Surg Oncol; 2007 Apr; 14(4):1285-7. PubMed ID: 17235719
[TBL] [Abstract][Full Text] [Related]
10. [Rectal carcinoma: is too much neoadjuvant therapy performed? Proposals for a more selective MRI based indication].
Junginger T; Hermanek P; Oberholzer K; Schmidberger H
Zentralbl Chir; 2006 Aug; 131(4):275-84. PubMed ID: 17004186
[TBL] [Abstract][Full Text] [Related]
11. Can increasing the dose of radiation by HDR brachytherapy boost following pre operative chemoradiotherapy for advanced rectal cancer improve surgical outcomes?
Sun Myint A; Mukhopadhyay T; Ramani VS; Perkins K; Snee AJ; Jelley F; Wong H; Lee CD
Colorectal Dis; 2010 Aug; 12 Suppl 2():30-6. PubMed ID: 20618365
[TBL] [Abstract][Full Text] [Related]
12. Rectal cancer: review with emphasis on MR imaging.
Beets-Tan RG; Beets GL
Radiology; 2004 Aug; 232(2):335-46. PubMed ID: 15286305
[TBL] [Abstract][Full Text] [Related]
13. [Quality for the data basis of evidence-based medicine: rectal cancer and preoperative 5 x 5 irradiation].
Kornmann M; Henne-Bruns D
Zentralbl Chir; 2008 Feb; 133(1):20-4. PubMed ID: 18278697
[TBL] [Abstract][Full Text] [Related]
14. [Rectal carcinoma--oncologically adequate resection].
Simon D
Praxis (Bern 1994); 2001 Apr; 90(14):575-80. PubMed ID: 11320884
[TBL] [Abstract][Full Text] [Related]
15. Individualized magnetic resonance imaging-based neoadjuvant chemoradiation for middle and lower rectal carcinoma.
Hermanek P; Hohenberger W; Fietkau R; Rödel C
Colorectal Dis; 2011 Jan; 13(1):39-47. PubMed ID: 19863611
[TBL] [Abstract][Full Text] [Related]
16. Radiation, chemotherapy and biological therapy in the curative treatment of locally advanced rectal cancer.
Gollins S
Colorectal Dis; 2010 Aug; 12 Suppl 2():2-24. PubMed ID: 20618363
[TBL] [Abstract][Full Text] [Related]
17. Management and imaging of low rectal carcinoma.
Salerno G; Daniels I; Heald RJ; Brown G; Moran BJ
Surg Oncol; 2004; 13(2-3):55-61. PubMed ID: 15572087
[TBL] [Abstract][Full Text] [Related]
18. Lymph node status and TS gene expression are prognostic markers in stage II/III rectal cancer after neoadjuvant fluorouracil-based chemoradiotherapy.
Liersch T; Langer C; Ghadimi BM; Kulle B; Aust DE; Baretton GB; Schwabe W; Häusler P; Becker H; Jakob C
J Clin Oncol; 2006 Sep; 24(25):4062-8. PubMed ID: 16943523
[TBL] [Abstract][Full Text] [Related]
19. The clinical significance of the circumferential resection margin following preoperative pelvic chemo-radiotherapy in rectal cancer: why we need a common language.
Glynne-Jones R; Mawdsley S; Novell JR
Colorectal Dis; 2006 Nov; 8(9):800-7. PubMed ID: 17032329
[TBL] [Abstract][Full Text] [Related]
20. Lymph node yield in rectal cancer surgery: effect of preoperative chemoradiotherapy.
Morcos B; Baker B; Al Masri M; Haddad H; Hashem S
Eur J Surg Oncol; 2010 Apr; 36(4):345-9. PubMed ID: 20071133
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
